Cargando…

Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells

Expression of the B‐cell antigen receptor (BCR) is essential not only for the development but also for the maintenance of mature B cells. Similarly, many B‐cell lymphomas, including Burkitt lymphoma (BL), require continuous BCR signaling for their tumor growth. This growth is driven by immunorecepto...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Xiaocui, Kläsener, Kathrin, Iype, Joseena M, Becker, Martin, Maity, Palash C, Cavallari, Marco, Nielsen, Peter J, Yang, Jianying, Reth, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983214/ https://www.ncbi.nlm.nih.gov/pubmed/29669863 http://dx.doi.org/10.15252/embj.201797980

Ejemplares similares

B cell activation involves nanoscale receptor reorganizations and inside-out signaling by Syk
por: Kläsener, Kathrin, et al.
Publicado: (2014)

Pten controls B‐cell responsiveness and germinal center reaction by regulating the expression of IgD BCR
por: Setz, Corinna S, et al.
Publicado: (2019)

The nanoscale organization of the B lymphocyte membrane()
por: Maity, Palash Chandra, et al.
Publicado: (2015)

CD20 as a gatekeeper of the resting state of human B cells
por: Kläsener, Kathrin, et al.
Publicado: (2021)

Chimeric antigen receptor T cells to target CD79b in B-cell lymphomas
por: Chu, Fuliang, et al.
Publicado: (2023)

United we stand: Double targeting of CD79B and CD20 in diffuse large B‐cell lymphoma
por: Tarantelli, Chiara, et al.
Publicado: (2022)

Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells
por: Camponeschi, Alessandro, et al.
Publicado: (2022)

CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
por: Trøen, Gunhild, et al.
Publicado: (2013)

TLR induces reorganization of the IgM-BCR complex regulating murine B-1 cell responses to infections
por: Savage, Hannah P, et al.
Publicado: (2019)

Quantitative proteomics identifies PTP1B as modulator of B cell antigen receptor signaling
por: Schwarz, Jennifer J, et al.
Publicado: (2021)

P1237: PRELIMINARY RESULTS OF A PHASE Ⅱ STUDY OF ZANUBRUTINIB COMBINED WITH IMMUNOCHEMOTHERAPY IN PATIENTS WITH CD79A/CD79B-MUTANT DIFFUSE LARGE B-CELL LYMPHOMA
por: Yan, Z., et al.
Publicado: (2022)

Anti‐CD22 and anti‐CD79b antibody‐drug conjugates preferentially target proliferating B cells
por: Fuh, Franklin K, et al.
Publicado: (2017)

Possible role of CD22, CD79b and CD20 expression in distinguishing small lymphocytic lymphoma from chronic lymphocytic leukemia
por: Jovanovic, Danijela, et al.
Publicado: (2014)

CD25 as a unique marker on human basophils in stable-mildly symptomatic allergic asthma
por: Iype, Joseena, et al.
Publicado: (2023)

Human CD79b(+) neutrophils in the blood are associated with early-stage melanoma
por: Meyer, Melissa A., et al.
Publicado: (2023)

Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations
por: Kersten, M J, et al.
Publicado: (2014)

Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice
por: Visco, Carlo, et al.
Publicado: (2020)

A symmetric geometry of transmembrane domains inside the B cell antigen receptor complex
por: Gottwick, Cornelia, et al.
Publicado: (2019)

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia
por: Lenk, Lennart, et al.
Publicado: (2022)

Basophils Orchestrating Eosinophils’ Chemotaxis and Function in Allergic Inflammation
por: Iype, Joseena, et al.
Publicado: (2021)

PIM1 and CD79B Mutation Status Impacts the Outcome of Primary Diffuse Large B-Cell Lymphoma of the CNS
por: Zhou, Jihao, et al.
Publicado: (2022)

Immunoglobulin expression in the endoplasmic reticulum shapes the metabolic fitness of B lymphocytes
por: Jumaa, Huda, et al.
Publicado: (2020)

iNKT Cells Suppress the CD8(+) T Cell Response to a Murine Burkitt’s-Like B Cell Lymphoma
por: Bjordahl, Ryan L., et al.
Publicado: (2012)

Combinatorial BTK and MALT1 inhibition augments killing of CD79 mutant diffuse large B cell lymphoma
por: Nagel, Daniel, et al.
Publicado: (2015)

High prevalence of oncogenic MYD88 and CD79B mutations in diffuse large B-cell lymphomas presenting at immune-privileged sites
por: Kraan, W, et al.
Publicado: (2013)

Clinicopathological significance of CD79a expression in classic Hodgkin lymphoma
por: Sakatani, Akio, et al.
Publicado: (2020)

Spleen Tyrosine Kinase Is Involved in the CD38 Signal Transduction Pathway in Chronic Lymphocytic Leukemia
por: Benkisser-Petersen, Marco, et al.
Publicado: (2016)

Peripheral T-Cell Lymphoma with Aberrant Expression of CD19, CD20, and CD79a: Case Report and Literature Review
por: Matnani, Rahul G., et al.
Publicado: (2013)

Molecular requirements of the B‐cell antigen receptor for sensing monovalent antigens
por: Volkmann, Christoph, et al.
Publicado: (2016)

High Levels of IL-10 and CD4+CD25hi+ Treg Cells in Endemic Burkitt’s Lymphoma Patients
por: Futagbi, Godfred, et al.
Publicado: (2015)

A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators
por: Pu, Dan, et al.
Publicado: (2022)

Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88/CD79B mutants‐enriched diffuse large B‐cell lymphomas
por: L'Imperio, Vincenzo, et al.
Publicado: (2022)

Small round tumour cells (CD38, CD 79a positive) in the adrenal gland
por: Nigam, L.A., et al.
Publicado: (2017)

EZH2 and CD79B mutational status over time in B-cell non-Hodgkin lymphomas detected by high-throughput sequencing using minimal samples
por: Saieg, Mauro Ajaj, et al.
Publicado: (2013)

Prevalence And Clinical Significance Of Oncogenic CD79B And MYD88 Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China
por: Chen, Yan-ping, et al.
Publicado: (2019)

Anti-CD79B Antibody–Drug Conjugate DCDS0780A in Patients with B-Cell Non-Hodgkin Lymphoma: Phase 1 Dose-Escalation Study
por: Herrera, Alex F., et al.
Publicado: (2022)

Occurrence of MYD88L265P and CD79B mutations in diffuse large b cell lymphoma with bone marrow infiltration: A case report
por: Huang, Wen-Ye, et al.
Publicado: (2022)

Expression of the B-Cell Receptor Component CD79a on Immature Myeloid Cells Contributes to Their Tumor Promoting Effects
por: Luger, Dror, et al.
Publicado: (2013)

CD79a promotes CNS-infiltration and leukemia engraftment in pediatric B-cell precursor acute lymphoblastic leukemia
por: Lenk, Lennart, et al.
Publicado: (2021)

Preliminary In Vitro Effects of CD8+ T Lymphocyte Specific for the CD20 Alternative Splicing D393-CD20 Peptide Expressed on Burkitt Lymphoma Cells
por: Chegni, Hamid, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nmolvu6d9k26etv2fbd0mriegb